web analytics

PANDAA® EBOV Qualification Panel

One assay. All known ebolaviruses.

PANDAA<span class="registered-symbol">®</span> EBOV Qualification Panel

For Research Use Only. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). PANDAA® is a registered trademark of Aldatu Biosciences. 

Overview

Shipping in early June.

Get in touch: ebola@aldatubio.com

Key Features

Technical Specifications

Analytical Sensitivity

Kit Contents

The PANDAA LASV Qualification Panel includes ten (10) samples made from synthetic, non-infectious RNA. Nine (9) positive panel members covering the target regions for the PANDAA assays in the Lassa virus genome of seven LASV isolates. The negative panel member (sample G) consists of the synthetic, non-infectious RNA from the equivalent genomic region of LCMV (lymphocytic choriomeningitis mammarenavirus), a closely related mammarenavirus. Synthetic RNA is prepared in a background of Internal Control RNA and human genomic DNA.
 

Label

LASV Isolate

Lineage

Copy Number

Volume

A

LP/Pinneo

I

5 copies / µL

200 µL

B

Josiah

IV

5 copies / µL

200 µL

C

Soromba-R

V

5 copies / µL

200 µL

D

Togo

VI

5 copies / µL

200 µL

E

Nig08-04

II

500 copies / µL

200 µL

F

Nig08-04

II

5 copies / µL

200 µL

G

LCMV *

–

500 copies / µL

200 µL

H

Nig08-A18

III

5,000 copies / µL

200 µL

I

Nig08-A18

III

500 copies / µL

200 µL

J

Nig08-A18

III

5 copies / µL

200 µL

For research use only (RUO). Not for use in diagnostic procedures.

Ordering

Email ebola@aldatubio.com

Get in touch

Documentation

Instructions for Use

Other Documentation

  • Safety data sheets (link)
  • Certificate of analysis (link)

Real-Time PCR Templates

Download real-time PCR template files from aldatu.bio/qpcr-templates

For Research Use Only. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). This product is covered by one or more patents, trademarks and / or copyrights owned or controlled by Aldatu Biosciences, Inc. PANDAA® is a registered trademark of Aldatu Biosciences, Inc. PANDAA primer and probe designs are proprietary to Aldatu Biosciences.

Order

Select your country from the dropdown to ensure that the correct pricing is shown for low- and middle-income countries.

$-

Documentation

Instructions for Use

Other Documentation

  • Safety data sheets (link)
  • Certificate of analysis (link)

Real-Time PCR Templates

Download real-time PCR template files from aldatu.bio/qpcr-templates

Kit Contents

The PANDAA LASV Qualification Panel includes ten (10) samples made from synthetic, non-infectious RNA. Nine (9) positive panel members covering the target regions for the PANDAA assays in the Lassa virus genome of seven LASV isolates. The negative panel member (sample G) consists of the synthetic, non-infectious RNA from the equivalent genomic region of LCMV (lymphocytic choriomeningitis mammarenavirus), a closely related mammarenavirus. Synthetic RNA is prepared in a background of Internal Control RNA and human genomic DNA.
 

Label

LASV Isolate

Lineage

Copy Number

Volume

A

LP/Pinneo

I

5 copies / µL

200 µL

B

Josiah

IV

5 copies / µL

200 µL

C

Soromba-R

V

5 copies / µL

200 µL

D

Togo

VI

5 copies / µL

200 µL

E

Nig08-04

II

500 copies / µL

200 µL

F

Nig08-04

II

5 copies / µL

200 µL

G

LCMV *

–

500 copies / µL

200 µL

H

Nig08-A18

III

5,000 copies / µL

200 µL

I

Nig08-A18

III

500 copies / µL

200 µL

J

Nig08-A18

III

5 copies / µL

200 µL

For research use only (RUO). Not for use in diagnostic procedures.

ACCOUNT

OUR COMPANY

RESOURCES

Facebook-f Linkedin-in

© 2014–2026 ALDATU BIOSCIENCES